Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 381

1.

p53 immunoexpression: an aid to conventional methods in the screening of precursor lesions of squamous esophageal cancer in patients at high-risk?

Fagundes RB, Melo CR, Pütten AC, Moreira LF, de Barros SG.

Cancer Detect Prev. 2005;29(3):227-32. Epub 2005 Apr 21.

PMID:
15936591
2.

Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus.

Fagundes RB, de Barros SG, Pütten AC, Mello ES, Wagner M, Bassi LA, Bombassaro MA, Gobbi D, Souto EB.

Endoscopy. 1999 May;31(4):281-5.

PMID:
10376452
3.

p53 protein in esophageal mucosa of individuals at high risk of squamous cell carcinoma of the esophagus.

Fagundes RB, Mello CR, Tollens P, Pütten AC, Wagner MB, Moreira LF, Barros SG.

Dis Esophagus. 2001;14(3-4):185-90.

PMID:
11869317
4.

The clinicopathologic significance of small areas unstained by Lugol's iodine in the mucosa surrounding resected esophageal carcinoma: an analysis of 147 cases.

Nakanishi Y, Ochiai A, Yoshimura K, Kato H, Shimoda T, Yamaguchi H, Tachimori Y, Watanabe H, Hirohashi S.

Cancer. 1998 Apr 15;82(8):1454-9.

PMID:
9554520
5.

Expression of p53 protein related to smoking and alcoholic beverage drinking habits in patients with esophageal cancers.

Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Tajima K, Masuda N, Tsukada K, Fukuda T, Nakajima T, Kuwano H.

Cancer Lett. 2001 Jun 10;167(1):65-72.

PMID:
11323100
6.

Expression of p53 in esophageal carcinoma with multiple areas unstained by iodine.

Yoshikawa M, Kato H, Miyazaki T, Nakajima M, Kamiyama Y, Fukai Y, Tajima K, Masuda N, Ojima H, Tsukada K, Kuwano H.

Hepatogastroenterology. 2005 Sep-Oct;52(65):1444-7.

PMID:
16201092
7.

Lugol chromoendoscopy as a diagnostic tool in so-called endoscopy-negative GERD.

Yoshikawa I, Yamasaki M, Yamasaki T, Kume K, Otsuki M.

Gastrointest Endosc. 2005 Nov;62(5):698-703; quiz 752, 754.

PMID:
16246682
8.

Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers.

Dubuc J, Legoux J-, Winnock M, Seyrig J-, Barbier J-, Barrioz T, Laugier R, Boulay G, Grasset D, Sautereau D, Grigoresco D, Butel J, Scoazec J-, Ponchon T; Société Française d'Endoscopie Digestive.

Endoscopy. 2006 Jul;38(7):690-5.

PMID:
16874909
9.

p53 overexpression in squamous cell carcinoma of the esophagus.

Baron PL, Gates CE, Reed CE, Dikeman RL, Drosieko JJ, Passmore RN, Bromberg JS, Willingham MC.

Ann Surg Oncol. 1997 Jan;4(1):37-45.

PMID:
8985516
10.

Lugol staining and histological evaluation of esophageal mucosa in achalasia.

Yamamuro EM, Cecconello I, Iriya K, El Ibrahim R, Rodrigues JG, Pinotti HW.

Hepatogastroenterology. 2006 Jul-Aug;53(70):506-10.

PMID:
16995450
11.

Histopathological evaluation including cytokeratin 13 and Ki-67 in the border between Lugol-stained and -unstained areas.

Ohta K, Ogawa I, Ono S, Taki M, Mizuta K, Miyauchi M, Takechi M, Shigeishi H, Takata T, Kamata N.

Oncol Rep. 2010 Jul;24(1):9-14.

PMID:
20514438
12.

Lugol dye endoscopy for analysis of esophageal mucosa in achalasia.

Yamamuro EM, Cecconello I, Iriya K, Tomishigue T, Oliveira MA, Pinotti HW.

Hepatogastroenterology. 1999 May-Jun;46(27):1687-91.

PMID:
10430322
13.

Evaluation of double vital staining with lugol's iodine and methylene blue in diagnosing superficial esophageal lesions.

Peng G, Long Q, Wu Y, Zhao J, Chen L, Li X.

Scand J Gastroenterol. 2011 Apr;46(4):406-13. doi: 10.3109/00365521.2010.545829. Epub 2010 Dec 29.

PMID:
21189106
14.

Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma.

Kawakubo H, Ozawa S, Ando N, Kitagawa Y, Mukai M, Ueda M, Kitajima M.

Oncol Rep. 2005 Dec;14(6):1453-9.

PMID:
16273238
15.

Family history of cancer, its combination with smoking and drinking, and risk of squamous cell carcinoma of the esophagus.

Garavello W, Negri E, Talamini R, Levi F, Zambon P, Dal Maso L, Bosetti C, Franceschi S, La Vecchia C.

Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1390-3.

16.

Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China.

Dawsey SM, Fleischer DE, Wang GQ, Zhou B, Kidwell JA, Lu N, Lewin KJ, Roth MJ, Tio TL, Taylor PR.

Cancer. 1998 Jul 15;83(2):220-31. Review.

PMID:
9669803
17.

Does daily alcohol and/or cigarette consumption cause low-grade dysplasia, a precursor of esophageal squamous cell carcinoma?

Kaneko K, Murakami Y, Katagiri A, Konishi K, Kubota Y, Muramoto T, Kushima M, Ohtsu A, Imawari M.

J Clin Gastroenterol. 2010 Mar;44(3):173-9. doi: 10.1097/MCG.0b013e3181bb837a.

PMID:
19826274
18.

DNA ploidy, P53 expression, and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi.

Itakura Y, Sasano F, Date F, Kato K, Sekine H, Mori S, Nagura H.

Anticancer Res. 1996 Jan-Feb;16(1):201-8.

PMID:
8615609
19.

p53 protein immunoexpression in esophageal squamous cell carcinoma and adjacent epithelium.

Chaves P, Pereira AD, Pinto A, Oliveira AG, Queimado L, Gloria L, Cardoso P, Mira FC, Soares J.

J Surg Oncol. 1997 May;65(1):3-9.

PMID:
9179260
20.

[The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].

Garozzo A, Cutrona D, Palmeri S, Maiolino L, Puzzo L, Allegra E.

Acta Otorhinolaryngol Ital. 1999 Dec;19(6):342-7. Italian.

PMID:
10875157

Supplemental Content

Support Center